ThinkSabio

$NVCR

$16.05▲ +0.5% YTD

3 SEC 13D/G filings tracked · Last updated Oct 1, 2026

Filing History
News
NVCR ▲ +0.5% - NovoCure Limited
CP $16.05▲ +0.5%Oct 1, 2026 · ThinkSabio Blog

$NVCR Novocure’s Optune Pax® Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancer…

News
NVCR ▲ +0.1% - NovoCure Limited
CP $17.38▲ +0.1%Sep 2, 2026 · ThinkSabio Blog

$NVCR - Novocure Announces Upcoming Investor Events…

News
NVCR ▼ -0.7% - NovoCure Limited
CP $17.51▲ -0.7%Sep 1, 2026 · ThinkSabio Blog

$NVCR - Novocure data breach affects more than 1,400 cancer patients -- BC…